Zobrazeno 1 - 10
of 19
pro vyhledávání: '"E O Ignatova"'
Autor:
M. Yu. Fedyanin, F. V. Moiseenko, M. A. Lyadova, V. N. Vorobyeva, V. V. Petkau, A. V. Fateeva, E. S. Kuzmina, O. Yu. Novikova, V. A. Chubenko, N. Kh. Abduloeva, A. A. Kudryavtsev, E. O. Ignatova, R. R. Shakirov, O. A. Pardabekova, L. V. Kindyalova, S. P. Pelikh, O. A. Gladkov, S. A. Tjulandin, A. A. Tryakin
Publikováno v:
Тазовая хирургия и онкология, Vol 11, Iss 1, Pp 11-20 (2021)
Objective: to compare the efficacy and tolerability of second‑line chemotherapy with original bevacizumab (Avastin) and biosimilar bevacizumab produced by “Biocad” (Avegra) in patients with metastatic colon cancer.Materials and methods. This re
Externí odkaz:
https://doaj.org/article/ab81d2b18b6d483387d0ba158a69a3b1
Autor:
E. O. Ignatova, D. A. Seryak, M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. F. Menshikova, Yu. V. Vakhabova, M. S. Karbyshev, K. V. Smirnova, S. A. Tulyandin
Publikováno v:
Успехи молекулярной онкологии, Vol 7, Iss 3, Pp 27-36 (2020)
Epstein–Barr virus (EBV) associated gastric carcinoma is a special form of gastric adenocarcinoma that arises against the background of clonal growth of EBV-infected epithelial cells of the gastric mucosa. This subtype of tumors has unique genetic
Externí odkaz:
https://doaj.org/article/14eaec726b784aa39fac2abcc0fb1713
Autor:
T. A. Bogush, A. S. Popova, E. A. Dudko, E. O. Ignatova, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 7-8, Pp 40-47 (2020)
The aim of the review was systematization of the data on discordance in expression of estrogen receptors between primary and metastatic breast cancer, different metastases and repeated analyses of the same tissue. The possible reasons for the phenome
Externí odkaz:
https://doaj.org/article/4ac97a55831a4873850c4cc5d4346603
Autor:
M. Yu. Fedyanin, Kh. Kh.-M. El’sunkaeva, I. A. Pokataev, A. A. Tryakin, A. A. Bulanov, O. V. Sekhina, D. A. Chekini, E. O. Ignatova, S. S. Gordeev, V. A. Aliev, D. V. Kuzmichev, Z. Z. Mamedli, M. V. Chernykh, V. V. Glebovskaya, S. I. Tkachev, N. A. Kozlov, S. A. Tjulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 8, Iss 2, Pp 24-37 (2018)
Objective: to evaluate the prognostic value of clinical and pathomorphological stages in patients with rectal cancer after preoperative chemoradiotherapy and to assess the effectiveness of adjuvant chemotherapy in these patients.Materials and methods
Externí odkaz:
https://doaj.org/article/149181908ade4da9b4b2d3bbdd53a71c
Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status
Autor:
M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, I. A. Pokataev, A. A. Tryakin, A. A. Bulanov, O. V. Sekhina, D. A. Chekini, E. O. Ignatova, S. S. Gordeev, M. D. Budurova, Z. Mamedli, D. V. Podluzhnyy, N. A. Kozlov, S. A. Tyulyandin
Publikováno v:
Тазовая хирургия и онкология, Vol 8, Iss 1, Pp 34-41 (2018)
Objective: to determine the efficacy of 2 oxaliplatin-based chemotherapy regimens (FOLFOX and XELOX) for metastatic colorectal cancer (CRC) depending on the KRAS mutation status and primary tumor location. Materials and methods. We performed retrospe
Externí odkaz:
https://doaj.org/article/f89e8956f46b4f8ea0792177ea22b12c
Autor:
A. I. Kalinkin, V. O. Sigin, E. O. Ignatova, M. A. Frolova, E. B. Kuznetsova, I. Y. Vinogradov, M. I. Vinogradov, I. I. Vinogradov, M. V. Nemtsova, D. V. Zaletaev, A. S. Tanas, V. V. Strelnikov
Publikováno v:
Russian Journal of Genetics. 58:835-843
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a207d0b897c4a3fb320ece83de6bc3
https://doi.org/10.1134/s1022795422070080
https://doi.org/10.1134/s1022795422070080
Autor:
E O Ignatova, O N Burdaeva, M V Kopp, B N Kotiv, D P Udovitsa, D L Stroiakovskii, S M Alekseev, L P Sheveleva, A V Khorinko, Iu S Shapovalova, V M Moiseenko, R A Ivanov
Publikováno v:
Современная онкология, Vol 18, Iss 2, Pp 39-47 (2016)
Objective. Within the multi-center double-blind randomized clinical study, investigate the bioequivalence (immediate efficacy, safety and pharmacokinetics) of BCD-022 (trastuzumab, JSC BIOCAD, Russia), as compared with Herceptin® (trastuzumab, F.Hof
Externí odkaz:
https://doaj.org/article/a2ddfb29e90a4971a38b8f7e9b03b151
Autor:
T P Kazubskaia, Alexander S. Zasedatelev, S M Portnoĭ, M A Emel'ianova, T. V. Nasedkina, Liubchenko Ln, O. E. Gromyko, E O Ignatova
Publikováno v:
Molecular Biology. 48:207-213
Germline mutations of BRCA1/2 genes cause the predisposition of their carriers to breast or/and ovary cancers (BC or/and OC) during the lifetime. Identification of these mutations is a basis of molecular diagnosis for BC susceptibility. Rapid genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2273fd7315b621307be9227ed8246c3
https://doi.org/10.1134/s0026893314020149
https://doi.org/10.1134/s0026893314020149
Autor:
T V, Nasedkina, O E, Gromyko, M A, Emel'ianova, E O, Ignatova, T P, Kazubskaia, S M, Portnoĭ, A S, Zasedatelev, L N, Liubchenko
Publikováno v:
Molekuliarnaia biologiia. 48(2)
Germline mutations of BRCA1/2 genes cause the predisposition of their carriers to breast or/and ovary cancers (BC or/and OC) during the lifetime. Identification of these mutations is a basis of molecular diagnosis for BC susceptibility. Rapid genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d16b478fb714f2798969aa0dd539c07f
https://pubmed.ncbi.nlm.nih.gov/25850293
https://pubmed.ncbi.nlm.nih.gov/25850293
Autor:
T A, Bogush, A S, Popova, E A, Dudko, E O, Ignatova, B E, Polotskiĭ, S A, Tiuliandin, M I, Davydov
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 58(7-8)
The aim of the review was systematization of the data on discordance in expression of estrogen receptors between primary and metastatic breast cancer, different metastases and repeated analyses of the same tissue. The possible reasons for the phenome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::adb6be6ec9d1fed77da057ff413edf25
https://pubmed.ncbi.nlm.nih.gov/24757833
https://pubmed.ncbi.nlm.nih.gov/24757833